Advertisement

Index by author

January 01, 1996; Volume 49,Issue 1

A

  1. Agnew, R

    1. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
      S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder
      Molecular Pharmacology January 1996, 49 (1) 105-111;

  2. Alam, M

    1. Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels.
      W Jarolimek, K V Soman, M Alam and A M Brown
      Molecular Pharmacology January 1996, 49 (1) 165-171;

  3. Albuquerque, E X

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  4. Allal, C

    1. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
      R B Clark, C Allal, J Friedman, M Johnson and R Barber
      Molecular Pharmacology January 1996, 49 (1) 182-189;

  5. Anastasiadis, P Z

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  6. Arai, A

    1. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
      M Kessler, A Arai, A Quan and G Lynch
      Molecular Pharmacology January 1996, 49 (1) 123-131;

B

  1. Barber, R

    1. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
      R B Clark, C Allal, J Friedman, M Johnson and R Barber
      Molecular Pharmacology January 1996, 49 (1) 182-189;

  2. Bernatowicz, M S

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

  3. Boeve, C M

    1. Inhibition of human interferon-gamma biosynthesis by an antisense RNA-expressing vector.
      C M Boeve, A V Wyngaerd and M De Ley
      Molecular Pharmacology January 1996, 49 (1) 58-62;

  4. Brown, A M

    1. Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels.
      W Jarolimek, K V Soman, M Alam and A M Brown
      Molecular Pharmacology January 1996, 49 (1) 165-171;

  5. Brown, F

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

  6. Bulseco, D A

    1. Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses.
      D A Bulseco and M I Schimerlik
      Molecular Pharmacology January 1996, 49 (1) 132-141;

C

  1. Cai, J J

    1. Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
      J J Cai and H C Lee
      Molecular Pharmacology January 1996, 49 (1) 81-88;

  2. Carruba, M O

    1. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
      E Nisoli, C Tonello, M Landi and M O Carruba
      Molecular Pharmacology January 1996, 49 (1) 7-14;

  3. Chang, S Y

    1. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
      J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle
      Molecular Pharmacology January 1996, 49 (1) 30-39;

  4. Clark, R B

    1. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
      R B Clark, C Allal, J Friedman, M Johnson and R Barber
      Molecular Pharmacology January 1996, 49 (1) 182-189;

D

  1. Daniel, D S

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  2. De Ley, M

    1. Inhibition of human interferon-gamma biosynthesis by an antisense RNA-expressing vector.
      C M Boeve, A V Wyngaerd and M De Ley
      Molecular Pharmacology January 1996, 49 (1) 58-62;

  3. Dickey, B F

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  4. Dopico, A M

    1. Ethanol increases the activity of large conductance, Ca(2+)-activated K+ channels in isolated neurohypophysial terminals.
      A M Dopico, J R Lemos and S N Treistman
      Molecular Pharmacology January 1996, 49 (1) 40-48;

  5. Dukat, M

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

  6. Duke, C C

    1. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
      S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder
      Molecular Pharmacology January 1996, 49 (1) 105-111;

E

  1. Escher, E

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  2. Euchenhofer, C

    1. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
      H Kleinert, C Euchenhofer, I Ihrig-Biedert and U Förstermann
      Molecular Pharmacology January 1996, 49 (1) 15-21;

F

  1. Fan, Z

    1. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
      J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle
      Molecular Pharmacology January 1996, 49 (1) 30-39;

  2. Fiedler, B

    1. Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
      J Redondo, B Fiedler and G Scheiner-Bobis
      Molecular Pharmacology January 1996, 49 (1) 49-57;

  3. Fishman, J B

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  4. Förstermann, U

    1. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
      H Kleinert, C Euchenhofer, I Ihrig-Biedert and U Förstermann
      Molecular Pharmacology January 1996, 49 (1) 15-21;

  5. Freissmuth, M

    1. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
      M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth
      Molecular Pharmacology January 1996, 49 (1) 73-80;

  6. Friedman, J

    1. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
      R B Clark, C Allal, J Friedman, M Johnson and R Barber
      Molecular Pharmacology January 1996, 49 (1) 182-189;

  7. Fukui, T

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

G

  1. Gaivin, R

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

  2. Glennon, R A

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

  3. Graham, R M

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

  4. Griendling, K K

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

  5. Guillemette, G

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  6. Guzelian, P S

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

H

  1. Hoffenberg, S

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  2. Hohenegger, M

    1. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
      M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth
      Molecular Pharmacology January 1996, 49 (1) 73-80;

  3. Holder, G M

    1. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
      S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder
      Molecular Pharmacology January 1996, 49 (1) 105-111;

  4. Hwa, J

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

I

  1. Ihrig-Biedert, I

    1. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
      H Kleinert, C Euchenhofer, I Ihrig-Biedert and U Förstermann
      Molecular Pharmacology January 1996, 49 (1) 15-21;

  2. Imerman, B A

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  3. Ismaiel, A M

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

  4. Izzarelli, D G

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

J

  1. Jarolimek, W

    1. Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels.
      W Jarolimek, K V Soman, M Alam and A M Brown
      Molecular Pharmacology January 1996, 49 (1) 165-171;

  2. Johnson, M

    1. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
      R B Clark, C Allal, J Friedman, M Johnson and R Barber
      Molecular Pharmacology January 1996, 49 (1) 182-189;

K

  1. Kai, H

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

  2. Kessler, M

    1. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
      M Kessler, A Arai, A Quan and G Lynch
      Molecular Pharmacology January 1996, 49 (1) 123-131;

  3. Kim, P M

    1. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
      P M Kim and P G Wells
      Molecular Pharmacology January 1996, 49 (1) 172-181;

  4. Kleinert, H

    1. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
      H Kleinert, C Euchenhofer, I Ihrig-Biedert and U Förstermann
      Molecular Pharmacology January 1996, 49 (1) 15-21;

  5. Klimas, C

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

  6. Kuhn, D M

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  7. Kyle, J W

    1. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
      J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle
      Molecular Pharmacology January 1996, 49 (1) 30-39;

L

  1. Landi, M

    1. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
      E Nisoli, C Tonello, M Landi and M O Carruba
      Molecular Pharmacology January 1996, 49 (1) 7-14;

  2. Laporte, S A

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  3. Lassègue, B

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

  4. Leduc, R

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  5. Lee, H C

    1. Protein kinase C isozyme-specific modulation of cyclic AMP-dependent phosphodiesterase in hypertrophic cardiomyopathic hamster hearts.
      J J Cai and H C Lee
      Molecular Pharmacology January 1996, 49 (1) 81-88;

  6. Lemos, J R

    1. Ethanol increases the activity of large conductance, Ca(2+)-activated K+ channels in isolated neurohypophysial terminals.
      A M Dopico, J R Lemos and S N Treistman
      Molecular Pharmacology January 1996, 49 (1) 40-48;

  7. Levine, R A

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  8. Limberis, J T

    1. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
      J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle
      Molecular Pharmacology January 1996, 49 (1) 30-39;

  9. Liu, S

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  10. Louie, M C

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  11. Lynch, G

    1. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
      M Kessler, A Arai, A Quan and G Lynch
      Molecular Pharmacology January 1996, 49 (1) 123-131;

M

  1. Maelicke, A

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  2. Makielski, J C

    1. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block.
      J C Makielski, J T Limberis, S Y Chang, Z Fan and J W Kyle
      Molecular Pharmacology January 1996, 49 (1) 30-39;

  3. Mathur, M

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

  4. Matsueda, G R

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

  5. Mayer, M L

    1. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
      K M Partin and M L Mayer
      Molecular Pharmacology January 1996, 49 (1) 142-148;

  6. McManus, M E

    1. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
      S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder
      Molecular Pharmacology January 1996, 49 (1) 105-111;

  7. Minieri, C A

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

  8. Misra, H K

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  9. Mitterauer, T

    1. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
      M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth
      Molecular Pharmacology January 1996, 49 (1) 73-80;

N

  1. Nanoff, C

    1. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
      M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth
      Molecular Pharmacology January 1996, 49 (1) 73-80;

  2. Nisoli, E

    1. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
      E Nisoli, C Tonello, M Landi and M O Carruba
      Molecular Pharmacology January 1996, 49 (1) 7-14;

  3. Noonan, T P

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

O

  1. Olianas, M C

    1. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology January 1996, 49 (1) 22-29;

  2. Onali, P

    1. Characterization of the G protein involved in the muscarinic stimulation of adenylyl cyclase of rat olfactory bulb.
      M C Olianas and P Onali
      Molecular Pharmacology January 1996, 49 (1) 22-29;

P

  1. Parker, E M

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

  2. Partin, K M

    1. Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI 53655.
      K M Partin and M L Mayer
      Molecular Pharmacology January 1996, 49 (1) 142-148;

  3. Peluso, M

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

  4. Pereira, E F

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  5. Perez, D M

    1. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor.
      D M Perez, J Hwa, R Gaivin, M Mathur, F Brown and R M Graham
      Molecular Pharmacology January 1996, 49 (1) 112-122;

  6. Pryor, K

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

Q

  1. Quan, A

    1. Effect of cyclothiazide on binding properties of AMPA-type glutamate receptors: lack of competition between cyclothiazide and GYKI 52466.
      M Kessler, A Arai, A Quan and G Lynch
      Molecular Pharmacology January 1996, 49 (1) 123-131;

R

  1. Redondo, J

    1. Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
      J Redondo, B Fiedler and G Scheiner-Bobis
      Molecular Pharmacology January 1996, 49 (1) 49-57;

  2. Richard, D E

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  3. Roberts-Thomson, S J

    1. Stereoselective and regioselective hydration of 7-methylbenz[c]acridine-5,6-oxide enantiomers by rodent and human microsomal epoxide hydrolases.
      S J Roberts-Thomson, M E McManus, C C Duke, R Agnew and G M Holder
      Molecular Pharmacology January 1996, 49 (1) 105-111;

  4. Roth, U

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  5. Rubins, J B

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

S

  1. Scheiner-Bobis, G

    1. Palytoxin-induced Na+ influx into yeast cells expressing the mammalian sodium pump is due to the formation of a channel within the enzyme.
      J Redondo, B Fiedler and G Scheiner-Bobis
      Molecular Pharmacology January 1996, 49 (1) 49-57;

  2. Schimerlik, M I

    1. Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses.
      D A Bulseco and M I Schimerlik
      Molecular Pharmacology January 1996, 49 (1) 132-141;

  3. Schrattenholz, A

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  4. Schuetz, E G

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

  5. Schuetz, J D

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

  6. Seiler, S M

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

  7. Servant, G

    1. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization.
      S A Laporte, G Servant, D E Richard, E Escher, G Guillemette and R Leduc
      Molecular Pharmacology January 1996, 49 (1) 89-95;

  8. Shah, A

    1. Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells.
      H Kai, T Fukui, B Lassègue, A Shah, C A Minieri and K K Griendling
      Molecular Pharmacology January 1996, 49 (1) 96-104;

  9. Shannon, T M

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  10. Soman, K V

    1. Structure-activity relationship of quaternary ammonium ions at the external tetraethylammonium binding site of cloned potassium channels.
      W Jarolimek, K V Soman, M Alam and A M Brown
      Molecular Pharmacology January 1996, 49 (1) 165-171;

  11. States, J C

    1. Mitogenic effects of tetrahydrobiopterin in PC12 cells.
      P Z Anastasiadis, J C States, B A Imerman, M C Louie, D M Kuhn and R A Levine
      Molecular Pharmacology January 1996, 49 (1) 149-155;

  12. Strom, S

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

  13. Sun, D

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

T

  1. Thottassery, J V

    1. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
      J D Schuetz, E G Schuetz, J V Thottassery, P S Guzelian, S Strom and D Sun
      Molecular Pharmacology January 1996, 49 (1) 63-72;

  2. Tonello, C

    1. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.
      E Nisoli, C Tonello, M Landi and M O Carruba
      Molecular Pharmacology January 1996, 49 (1) 7-14;

  3. Treistman, S N

    1. Ethanol increases the activity of large conductance, Ca(2+)-activated K+ channels in isolated neurohypophysial terminals.
      A M Dopico, J R Lemos and S N Treistman
      Molecular Pharmacology January 1996, 49 (1) 40-48;

  4. Tuttle, J G

    1. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists.
      S M Seiler, M Peluso, J G Tuttle, K Pryor, C Klimas, G R Matsueda and M S Bernatowicz
      Molecular Pharmacology January 1996, 49 (1) 190-197;

V

  1. Voss, T

    1. Thiophosphorylation of the G protein beta subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G alpha subunits.
      M Hohenegger, T Mitterauer, T Voss, C Nanoff and M Freissmuth
      Molecular Pharmacology January 1996, 49 (1) 73-80;

W

  1. Weber, K H

    1. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
      A Schrattenholz, E F Pereira, U Roth, K H Weber, E X Albuquerque and A Maelicke
      Molecular Pharmacology January 1996, 49 (1) 1-6;

  2. Wells, P G

    1. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
      P M Kim and P G Wells
      Molecular Pharmacology January 1996, 49 (1) 172-181;

  3. Westkaemper, R B

    1. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
      R A Glennon, M Dukat, R B Westkaemper, A M Ismaiel, D G Izzarelli and E M Parker
      Molecular Pharmacology January 1996, 49 (1) 198-206;

  4. Wright, G E

    1. Specific and effective interaction of a guanine nucleotide analogue with small G proteins.
      S Hoffenberg, T M Shannon, T P Noonan, S Liu, D S Daniel, J B Fishman, J B Rubins, H K Misra, G E Wright and B F Dickey
      Molecular Pharmacology January 1996, 49 (1) 156-164;

  5. Wyngaerd, A V

    1. Inhibition of human interferon-gamma biosynthesis by an antisense RNA-expressing vector.
      C M Boeve, A V Wyngaerd and M De Ley
      Molecular Pharmacology January 1996, 49 (1) 58-62;
Back to top

In this issue

Advertisement